We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 229.41%
This Fund
S&P 500
This Quarter Est. Return
+24.25%
1 Year Est. Return
+229.41%
3 Year Est. Return
+810.62%
5 Year Est. Return
+1,830.01%
10 Year Est. Return
+67,312.86%
AUM
$518M
AUM Growth
+$42.9M
Cap. Flow
+$39.4M
Cap. Flow %
7.62%
Top 10 Hldgs %
30.31%
Holding
98
New
21
Increased
21
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$11.4M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
THO icon
Thor Industries
THO
+$8.71M
4
CNC icon
Centene
CNC
+$7.27M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$7.27M

Top Sells

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$8.32M
2
MDCO
Medicines Co
MDCO
+$8.27M
3
DIS icon
Walt Disney
DIS
+$6.25M
4
QTWO icon
Q2 Holdings
QTWO
+$5.91M
5
ROKU icon
Roku
ROKU
+$5.36M

Sector Composition

Rank Sector Weight
1 Healthcare 35.86%
2 Technology 16.92%
3 Consumer Discretionary 12.84%
4 Communication Services 10.59%
5 Miscellaneous 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
– –
-238,500
Closed -$20.6M
INSP icon
2
Inspire Medical Systems
INSP
$1.8B
$19.7M 3.8%
265,000
+41,000
+18% +$2.64M
AMZN icon
3
Amazon
AMZN
$2.77T
$15.5M 3%
168,000
+22,000
+15% +$1.95M
MSFT icon
4
Microsoft
MSFT
$3.67T
$15.5M 2.98%
98,000
+21,000
+27% +$3.09M
NFLX icon
5
Netflix
NFLX
$320B
$14.2M 2.75%
440,000
-80,000
-15% -$2.37M
BATRK icon
6
Atlanta Braves Holdings Series B
BATRK
$3.24B
$13.6M 2.62%
458,900
+9,064
+2% +$258K
RETA
7
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$12.8M 2.47%
+62,500
New +$11.4M
KMX icon
8
CarMax
KMX
$8.6B
$12.6M 2.44%
144,000
+17,000
+13% +$1.6M
ZLAB icon
9
Zai Lab
ZLAB
$2.85B
$11.9M 2.29%
285,000
-19,900
-7% -$735K
RNG icon
10
RingCentral
RNG
$5.86B
$11.8M 2.28%
70,000
-6,000
-8% -$989K
ENPH icon
11
Enphase Energy
ENPH
$5.13B
$11.6M 2.25%
445,600
+150,600
+51% +$3.43M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.1T
$11.2M 2.17%
+168,000
New +$10.8M
MLM icon
13
Martin Marietta Materials
MLM
$36.4B
$10.9M 2.11%
39,000
-6,400
-14% -$1.71M
DXCM icon
14
DexCom
DXCM
$31.9B
$10.3M 1.99%
188,000
+20,000
+12% +$949K
ROKU icon
15
Roku
ROKU
$23.1B
$10M 1.94%
75,000
-39,000
-34% -$5.36M
THO icon
16
Thor Industries
THO
$3.86B
$10M 1.94%
+135,000
New +$8.71M
SRPT icon
17
Sarepta Therapeutics
SRPT
$2.21B
$9.29M 1.79%
+72,000
New +$7.27M
EHTH icon
18
eHealth
EHTH
$31.3M
$9.08M 1.75%
94,500
-40,500
-30% -$3.14M
TW icon
19
Tradeweb Markets
TW
$21.7B
$9.03M 1.74%
194,800
+56,000
+40% +$2.41M
ISRG icon
20
Intuitive Surgical
ISRG
$124B
$8.87M 1.71%
45,000
-3,000
-6% -$562K
TEAM icon
21
Atlassian
TEAM
$44.7B
$8.79M 1.7%
73,000
-11,000
-13% -$1.34M
CNC icon
22
Centene
CNC
$31.9B
$8.43M 1.63%
+134,000
New +$7.27M
GO icon
23
Grocery Outlet
GO
$1.16B
$7.95M 1.53%
245,000
+33,500
+16% +$1.08M
COUP
24
DELISTED
Coupa Software Incorporated
COUP
$7.9M 1.52%
54,000
-13,000
-19% -$1.86M
RGEN icon
25
Repligen
RGEN
$9.51B
$7.86M 1.52%
85,000
+15,000
+21% +$1.26M
1
2 3 4

Similar funds

ACM
Adelante Capital Management Alameda, California $1.52B AUM 23.15% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return

Atika Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Atika Capital Management held 98 positions worth $518M, up 9% from $475M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atika Capital Management deployed $39.4M of net new capital in Q4 2019, opening 21 new positions and adding to 21 existing holdings. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 62,500 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Roku, an estimated $5.36M trimmed.

  • Atika Capital Management's largest Q4 2019 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 62,500 shares worth $12.8M.
  • Atika Capital Management added most to Enphase Energy in Q4 2019, an estimated $3.43M increase.
  • Atika Capital Management's biggest Q4 2019 reduction was Roku, cutting an estimated $5.36M.
  • Atika Capital Management fully exited Twitter, Inc. in Q4 2019, selling an estimated $8.32M.
  • Atika Capital Management's ten largest holdings make up 30% of its $518M portfolio in Q4 2019.
  • Atika Capital Management opened 21 new positions and closed 25 in Q4 2019.
  • Atika Capital Management's portfolio value rose 9% quarter-over-quarter to $518M.

Based on Atika Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.